We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current ATNFW market cap is 67.28k. The company's latest EPS is USD -2.6669 and P/E is -0.73.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -22.93M | -20.31M | -4.8M | -3.68M | -12.6M |
| Net Income | -21.49M | -21.74M | -4.76M | -3.68M | -10.27M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -1.21M | -5.65M | -15.64M | -51.45M | -22.54M |
| Net Income | -91k | -10.88M | -20.32M | -38.73M | -19.94M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 34.34M | 19.65M | 14.92M | 13.67M | 4.96M |
| Total Liabilities | 8.26M | 8.31M | 7.78M | 6.95M | 5.11M |
| Total Equity | 26.08M | 11.34M | 7.14M | 6.72M | -149k |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 12.5M | 55.53M | 62.71M | 19.65M | 5.26M |
| Total Liabilities | 7.16M | 25.25M | 23.39M | 8.31M | 5.39M |
| Total Equity | 5M | 30.29M | 39.32M | 11.34M | -128k |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -9.2M | -12.13M | -3.87M | -6.99M | -8.76M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 4.48M | 10.87M | -470k | 1.99M | 4.44M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -1.45M | -3.87M | -19.37M | -12.13M | -10.92M |
| Investing | 108.24M | 14.49M | N/A | N/A | N/A |
| Financing | -106.51M | -8.73M | 25.41M | 10.87M | 5.91M |
| Market Cap | 67.28k |
| Price to Earnings Ratio | -0.73 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 7.38 |
| Price to Book Ratio | -113.88 |
| Dividend Yield | - |
| Shares Outstanding | 7.48M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0 (3.23%) |
| Company Name | 180 Life Sciences Corporation |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.180lifesciences.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
